)
)
Genes2Me
)
G2M is a highly innovative technology developer in the In-Vitro Diagnostics industry, creating solutions for point-of-care testing, next generation sequencing, RT-PCR and extraction solutions. The firm has 150+ CE-IVD approved solutions including 29+ CE-IVD approved NGS clinical panels, 90+ RT-PCR Kits, 50+ Point-of-care kits and point-of-care instruments. Exporting these solutions to 60+ countries across the globe, the firm has created a new wave in the IVD global landscape, providing superior technology with end-to-end solutions to end users.